Inventor

MASUDA ESTEBAN

US84 patents

⚠️ This page may combine multiple inventors who share the name “MASUDA ESTEBAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MASUDA ESTEBAN

RIGEL PHARMACEUTICALS INC

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

RIP1 inhibitory compounds and methods for making and using the same

Compositions and methods for inhibition of the JAK pathway

2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Protein kinase C inhibitors and uses thereof

Protein kinase C inhibitors and uses thereof

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Methods and compositions for treating degenerative bone disorders

Kinase inhibitors and their uses

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Compounds and method for treating autoimmune diseases

Tyrosine kinase inhibitors

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Protein kinase C inhibitors and uses thereof

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Protein kinase C inhibitors and uses thereof

Compositions and methods for inhibition of the JAK pathway

Protein kinase C inhibitors and uses thereof

Protein kinase C inhibitors and uses thereof

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

Methods and compositions for screening for altered cellular phenotypes

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Compositions and methods for inhibition of the JAK pathway

RIP1 inhibitory compounds and methods for making and using the same

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade

Kinase inhibitors and their uses

RIP1K inhibitors

Method for treatment of COVID-19-associated conditions

SINGH RAJINDER

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

BHAMIDIPATI SOMASEKHAR

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

MASUDA ESTEBAN

Methods of treating cell proliferative disorders

Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis

HOLLAND SACHA

Protein kinase C inhibitors and uses thereof

ARGADE ANKUSH

Compositions and methods for inhibition of the JAK pathway

LI HUI

Compositions and methods for inhibition of the JAK pathway